BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9040635)

  • 21. Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage--importance of endogenous oxygen free radical scavengers in red blood cells.
    Julia PL; Buckberg GD; Acar C; Partington MT; Sherman MP
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):303-13. PubMed ID: 1992241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-blood (miniplegia) versus dilute cardioplegia in experimental surgical revascularization of evolving infarction.
    Velez DA; Morris CD; Budde JM; Muraki S; Otto RN; Guyton RA; Vinten-Johansen J
    Circulation; 2001 Sep; 104(12 Suppl 1):I296-302. PubMed ID: 11568072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a nitric oxide precursor to protect pig myocutaneous flaps from ischemia-reperfusion injury.
    Cordeiro PG; Santamaria E; Hu QY
    Plast Reconstr Surg; 1998 Nov; 102(6):2040-8; discussion 2049-51. PubMed ID: 9811002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion.
    Lefer DJ; Nakanishi K; Vinten-Johansen J
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S34-43. PubMed ID: 7504767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous manipulation of the nitric oxide and prostanoid pathways reduces myocardial reperfusion injury.
    Wanna FS; Obayashi DY; Young JN; DeCampli WM
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1054-62. PubMed ID: 7475134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of controlled reperfusion after ischemia. XX. Reperfusate composition: detrimental effects of initial asanguineous cardioplegic washout after acute coronary occlusion.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):294-302. PubMed ID: 1992240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide attenuates cardiomyocytic apoptosis via diminished mitochondrial complex I up-regulation from cardiac ischemia-reperfusion injury under cardiopulmonary bypass.
    Yeh CH; Lin YM; Wu YC; Wang YC; Lin PJ
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):180-8. PubMed ID: 15282453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes.
    Hayashi Y; Sawa Y; Fukuyama N; Miyamoto Y; Takahashi T; Nakazawa H; Matsuda H
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1813-21. PubMed ID: 14688692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats.
    Liu P; Yin K; Nagele R; Wong PY
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1139-46. PubMed ID: 9495876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The influence of L-arginine on secretion of nitric oxide and haemodynamic function of isolated rat's heart subjected to cold cardioplegic ischemia and reperfusion].
    Okoński P; Szram S; Banach M; Mussur M; Zasłonka J
    Przegl Lek; 2004; 61(7):789-93. PubMed ID: 15792023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.
    Zhao ZQ; Corvera JS; Halkos ME; Kerendi F; Wang NP; Guyton RA; Vinten-Johansen J
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H579-88. PubMed ID: 12860564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
    Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization.
    Riley RD; Sato H; Zhao ZQ; Thourani VH; Jordan JE; Fernandez AX; Ma XL; Hite DR; Rigel DF; Pellas TC; Peppard J; Bill KA; Lappe RW; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):350-8. PubMed ID: 10917953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive effects of L-arginine infusion and leukocyte depletion on recovery after hypothermic ischemia in neonatal lamb hearts.
    Hiramatsu T; Forbess JM; Miura T; Nomura F; Mayer JE
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):172-9. PubMed ID: 7609541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes.
    Zhao ZQ; Nakamura M; Wang NP; Wilcox JN; Shearer S; Guyton RA; Vinten-Johansen J
    Coron Artery Dis; 1999 Dec; 10(8):617-28. PubMed ID: 10599541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs.
    Yao Z; Rasmussen JL; Hirt JL; Mei DA; Pieper GM; Gross GJ
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):653-63. PubMed ID: 7505370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy.
    Lefer AM
    Ann Thorac Surg; 1995 Sep; 60(3):847-51. PubMed ID: 7677545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloricromene reduces infarct size and alters postischaemic blood flow defects in dog myocardium.
    Groban L; Zvara DA; Deal DD; Vernon JC; Flye CW; Ma XL; Vinten-Johansen J
    Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):417-23. PubMed ID: 9673816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-arginine improves hemodynamic function and coronary flow in an experimental model of ischemia-reperfusion injury.
    Okoński P; Banach M; Rysz J; Barylski M; Irzmański R; Piechota M; Zasłonka J
    Ann Transplant; 2006; 11(1):28-34. PubMed ID: 17025027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.